{"mainPropery":{"diseaseId":7918,"diseaseName":"Zollinger-Ellison syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7918/zollinger-ellison-syndrome","synonyms":["ZES","Gastrinoma","Pancreatic ulcerogenic tumor syndrome","Z E syndrome"],"synonyms-with-source":[{"name":"ZES"},{"name":"Gastrinoma"},{"name":"Pancreatic ulcerogenic tumor syndrome"},{"name":"Z E syndrome"}],"identifiers":[{"identifierType":"OMIM","identifierId":"131100"},{"identifierType":"ORPHANET","identifierId":"913"}]},"diseaseCategories":[{"diseaseTypeId":6,"diseaseTypeName":"Digestive Diseases","source":"Orphanet"},{"diseaseTypeId":8,"diseaseTypeName":"Endocrine Diseases","source":"Orphanet"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[{"resourceID":638,"resourceName":"Association for Multiple Endocrine Neoplasia Disorders (AMEND)","abbreviation":"UK, New Zealand, and USA","address1":"The Warehouse","address2":"No 1 Draper Street","address3":"Southborough","address4":"Tunbridge Wells Kent TN4 0PG","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"+ 44 (0)1892 516076","tty":"","tollFree":"","fax":"","email":"info@amend.org.uk","url":"http://www.amend.org.uk","freeText":""},{"resourceID":2417,"resourceName":"American Multiple Endocrine Neoplasia Support","abbreviation":"","address1":"1027 Hampshire Drive","address2":"","address3":"","address4":"","address5":"","city":"Maryville","state":"TN","zip":"37801","country":"","phone":"865-238-5842","tty":"","tollFree":"","fax":"","email":"http://amensupport.org/contact%20us","url":"http://www.amensupport.org/","freeText":""},{"resourceID":2732,"resourceName":"NET Patient Foundation","abbreviation":"UK and Ireland","address1":"Holly House (2nd Floor)","address2":"74 Upper Holly Walk","address3":"Leamington Spa","address4":"","address5":"","city":"Warwickshire","state":"","zip":"CV32 4JL","country":"United Kingdom","phone":"01926 883487 (General inquieries)","tty":"","tollFree":"0800 434 6476 (Helpline)","fax":"","email":"hello@netpatientfoundation.org","url":"https://www.netpatientfoundation.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/131100' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=zollinger%5BTitle%5D%20AND%20ellison%5BTitle%5D%20AND%20syndrome%5BTitle%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Zollinger-Ellison syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Zollinger-Ellison+syndrome%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Zollinger-Ellison syndrome. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/360/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000325.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/183555-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=913' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1536,"resourceId":2167,"resourceName":"National Kidney and Urologic Diseases Information Clearinghouse","descriptionText":"The <a href='http://digestive.niddk.nih.gov/ddiseases/pubs/zollinger/' target='_blank'>National Kidney and Urologic Diseases Information Clearinghouse</a> (NKUDIC), part of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), provides information on this topic. You can contact the NKUDIC by calling toll-free 800-891-5390 or by visiting their Web site.  ","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merck.com/mmpe/sec02/ch021/ch021j.html#sec02-ch021-ch021h-1582' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1557,"resourceId":2183,"resourceName":"National Digestive Diseases Information Clearinghouse","descriptionText":"The <a href='http://www.digestive.niddk.nih.gov/ddiseases/pubs/zollinger/' target='_blank'>National Digestive Diseases Information Clearinghouse</a> (NIDDK) offers information on this condition.  Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:0050782' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6516,"questionText":"What is Zollinger-Ellison syndrome?","answerText":"<strong>Zollinger-Ellison syndrome (ZES)&nbsp;</strong>is a condition in which tumors called <a href=\"http://www.cancerresearchuk.org/cancer-help/about-cancer/cancer-questions/gastrinomas\" target=\"_blank\">gastrinomas</a> in the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/8883.htm\" target=\"_blank\">pancreas</a> and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002347.htm\" target=\"_blank\">duodenum</a> (part of the small intestine) cause high levels of the hormone gastrin in the blood. High levels of gastrin then cause production of too much stomach acid. Signs and symptoms may include abdominal pain, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000206.htm\" target=\"_blank\">peptic ulcers</a>, vomiting blood, and diarrhea.[7092][7093] The tumors are sometimes cancerous and may spread to other areas of the body.[7094] In most cases, the cause of ZES is unknown. However, about 25-30% of gastrinomas are caused by an inherited condition called <a href=\"http://ghr.nlm.nih.gov/condition=multipleendocrineneoplasia\" target=\"_blank\">multiple endocrine neoplasia type 1</a><a href=\"http://ghr.nlm.nih.gov/condition=multipleendocrineneoplasia\" target=\"_blank\"> (MEN1)</a>. Treatment for ZES may include medication to reduce the production of stomach acid, and surgery for peptic ulcers or to remove tumors.[5599]","dateModified":"2014-01-14T10:57:00"},"basicQuestions":[{"questionId":7198,"questionText":"What causes Zollinger-Ellison syndrome?","answerText":"In most people with Zollinger-Ellison syndrome (ZES), the cause is not known. However, in about 25-30% of cases, it occurs with an inherited condition called <a href=\"http://ghr.nlm.nih.gov/condition/multiple-endocrine-neoplasia\" target=\"_blank\">multiple endocrine neoplasia type 1 (MEN1)</a>. This condition is caused by changes (mutations) in the <em><a href=\"http://ghr.nlm.nih.gov/gene/MEN1\" target=\"_blank\">MEN1</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. Most, but not all, individuals with an <em>MEN1</em> gene mutation will develop symptoms of multiple endocrine neoplasia type 1.[7094][7095]<br />\r\n<br />\r\nThe <em>MEN1</em> gene normally regulates the body's production of a protein thought to play a role in preventing the development of tumors (a tumor suppressor gene). Mutations that affect the function of this gene therefore affect the body's ability to prevent the growth of tumors, thus leading the the signs and symptoms of multiple endocrine neoplasia type 1.[7095]","dateModified":"2014-01-14T11:42:00","resourceClassificationName":"Cause","references":[{"referenceId":7094,"authors":"","articleTitle":"Zollinger-Ellison Syndrome","bookWebsiteJournalTitle":"National Digestive Diseases  Information Clearinghouse (NDDIC)","date":"December 24, 2013","volume":"","pages":"","url":"http://www.digestive.niddk.nih.gov/ddiseases/pubs/zollinger/","dateAccessed":"2014-01-14T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7095,"authors":"","articleTitle":"Zollinger Ellison syndrome","bookWebsiteJournalTitle":"NORD","date":"January 20, 2012","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/360/viewAbstract","dateAccessed":"2014-01-14T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7196,"questionText":"Is Zollinger-Ellison syndrome inherited?","answerText":"Zollinger-Ellison syndrome (ZES) usually occurs sporadically, for unknown reasons in a person with no history of the condition in the family. In about 25-30% of people with ZES, it is associated with an inherited condition called <a href=\"http://ghr.nlm.nih.gov/condition/multiple-endocrine-neoplasia\" target=\"_blank\">multiple endocrine neoplasia type 1 (MEN1)</a>.[7094]<br />\r\n<br />\r\nMEN1 is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner and is caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/MEN1\" target=\"_blank\">MEN1</a></em> gene. Most affected people inherit the mutated gene from a parent, and a few cases result from a new mutation that was not inherited. Unlike most autosomal dominant conditions, both copies of the <em>MEN1</em> gene must have a mutation to cause symptoms of the condition. The mutation in the second copy of the gene occurs during a person's lifetime. Because of this, most, but not all, people born with an <em>MEN1</em> gene mutation will develop signs and symptoms of the condition.[7096] This phenomenon is known as <a href=\"http://ghr.nlm.nih.gov/handbook/inheritance/penetranceexpressivity\" target=\"_blank\">reduced penetrance</a>. A person with an <em>MEN1</em> gene mutation has a 50% (1 in 2) risk to pass on the mutated gene to each child.","dateModified":"2014-01-14T12:03:00","resourceClassificationName":"Inheritance","references":[{"referenceId":7094,"authors":"","articleTitle":"Zollinger-Ellison Syndrome","bookWebsiteJournalTitle":"National Digestive Diseases  Information Clearinghouse (NDDIC)","date":"December 24, 2013","volume":"","pages":"","url":"http://www.digestive.niddk.nih.gov/ddiseases/pubs/zollinger/","dateAccessed":"2014-01-14T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7096,"authors":"","articleTitle":"Multiple endocrine neoplasia","bookWebsiteJournalTitle":"Genetics Home Reference","date":"August, 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/multiple-endocrine-neoplasia","dateAccessed":"2014-01-14T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7195,"questionText":"Is genetic testing available for Zollinger-Ellison syndrome?","answerText":"There is not a genetic test specifically for Zollinger-Ellison syndrome (ZES), which usually occurs sporadically as a result of a tumor that secretes gastrin (a gastrinoma). However, genetic testing is available for multiple endocrine neoplasia type 1 (MEN1), which is a genetic condition present in about 25-30% of people with ZES.<br />\r\n<br />\r\nPeople who have a single MEN1-related tumor (such as one gastrinoma) and no family history of multiple endocrine neoplasia type 1 are rarely born with <em>MEN1</em> gene mutations. Generally, the chance of detecting a <em>MEN1</em> gene mutation increases in people with more main tumors (parathyroid, pancreatic, and pituitary).[7103]<br />\r\n<br />\r\nGenetic testing is most informative for asymptomatic family members when the affected family member has genetic testing first. The person with symptoms of MEN1 typically first has sequencing analysis of the gene to look for changes; if no mutation is found, they may have duplication/deletion analysis (a test that detects extra or missing parts of the gene).[7103]<br />\r\n<br />\r\nPredictive testing for at-risk, asymptomatic, adult family members requires first finding the disease-causing mutation in the affected family member. It is important to note that in people with a <em>MEN1</em> gene mutation, the chance to develop symptoms by age 20 is over 50%. The chance to develop symptoms by age 40 is 95%.[7103] Therefore, as a person ages and does not have signs or symptoms, the chance to have a <em>MEN1</em> gene mutation decreases significantly.<br />\r\n<br />\r\nThe <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0025267/\" target=\"_blank\">Genetic Testing Registry (GTR)</a> provides information about the genetic tests for multiple endocrine neoplasia type 1. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.","dateModified":"2014-01-14T15:35:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":7103,"authors":"Francesca Giusti, Francesca Marini, and Maria Luisa Brandi","articleTitle":"Multiple Endocrine Neoplasia Type 1","bookWebsiteJournalTitle":"GeneReviews","date":"February 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1538/","dateAccessed":"2014-04-05T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":43225,"abbreviatedInquiry":"My dad had ZE syndrome and passed away at age 31. Are there genetic tests that could be done to see if my brother and I carry this gene? I have a gastro specialist and he tests my gastric levels every year for this reason. I have mixed feelings about knowing if I have the gene or not.","caseQuestions":[{"questionId":7198,"questionText":"What causes Zollinger-Ellison syndrome?","answerText":"In most people with Zollinger-Ellison syndrome (ZES), the cause is not known. However, in about 25-30% of cases, it occurs with an inherited condition called <a href=\"http://ghr.nlm.nih.gov/condition/multiple-endocrine-neoplasia\" target=\"_blank\">multiple endocrine neoplasia type 1 (MEN1)</a>. This condition is caused by changes (mutations) in the <em><a href=\"http://ghr.nlm.nih.gov/gene/MEN1\" target=\"_blank\">MEN1</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. Most, but not all, individuals with an <em>MEN1</em> gene mutation will develop symptoms of multiple endocrine neoplasia type 1.[7094][7095]<br />\r\n<br />\r\nThe <em>MEN1</em> gene normally regulates the body's production of a protein thought to play a role in preventing the development of tumors (a tumor suppressor gene). Mutations that affect the function of this gene therefore affect the body's ability to prevent the growth of tumors, thus leading the the signs and symptoms of multiple endocrine neoplasia type 1.[7095]","dateModified":"2014-01-14T11:42:00","resourceClassificationName":"Cause","references":[{"referenceId":7094,"authors":"","articleTitle":"Zollinger-Ellison Syndrome","bookWebsiteJournalTitle":"National Digestive Diseases  Information Clearinghouse (NDDIC)","date":"December 24, 2013","volume":"","pages":"","url":"http://www.digestive.niddk.nih.gov/ddiseases/pubs/zollinger/","dateAccessed":"2014-01-14T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7095,"authors":"","articleTitle":"Zollinger Ellison syndrome","bookWebsiteJournalTitle":"NORD","date":"January 20, 2012","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/360/viewAbstract","dateAccessed":"2014-01-14T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7196,"questionText":"Is Zollinger-Ellison syndrome inherited?","answerText":"Zollinger-Ellison syndrome (ZES) usually occurs sporadically, for unknown reasons in a person with no history of the condition in the family. In about 25-30% of people with ZES, it is associated with an inherited condition called <a href=\"http://ghr.nlm.nih.gov/condition/multiple-endocrine-neoplasia\" target=\"_blank\">multiple endocrine neoplasia type 1 (MEN1)</a>.[7094]<br />\r\n<br />\r\nMEN1 is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner and is caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/MEN1\" target=\"_blank\">MEN1</a></em> gene. Most affected people inherit the mutated gene from a parent, and a few cases result from a new mutation that was not inherited. Unlike most autosomal dominant conditions, both copies of the <em>MEN1</em> gene must have a mutation to cause symptoms of the condition. The mutation in the second copy of the gene occurs during a person's lifetime. Because of this, most, but not all, people born with an <em>MEN1</em> gene mutation will develop signs and symptoms of the condition.[7096] This phenomenon is known as <a href=\"http://ghr.nlm.nih.gov/handbook/inheritance/penetranceexpressivity\" target=\"_blank\">reduced penetrance</a>. A person with an <em>MEN1</em> gene mutation has a 50% (1 in 2) risk to pass on the mutated gene to each child.","dateModified":"2014-01-14T12:03:00","resourceClassificationName":"Inheritance","references":[{"referenceId":7094,"authors":"","articleTitle":"Zollinger-Ellison Syndrome","bookWebsiteJournalTitle":"National Digestive Diseases  Information Clearinghouse (NDDIC)","date":"December 24, 2013","volume":"","pages":"","url":"http://www.digestive.niddk.nih.gov/ddiseases/pubs/zollinger/","dateAccessed":"2014-01-14T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7096,"authors":"","articleTitle":"Multiple endocrine neoplasia","bookWebsiteJournalTitle":"Genetics Home Reference","date":"August, 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/multiple-endocrine-neoplasia","dateAccessed":"2014-01-14T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7195,"questionText":"Is genetic testing available for Zollinger-Ellison syndrome?","answerText":"There is not a genetic test specifically for Zollinger-Ellison syndrome (ZES), which usually occurs sporadically as a result of a tumor that secretes gastrin (a gastrinoma). However, genetic testing is available for multiple endocrine neoplasia type 1 (MEN1), which is a genetic condition present in about 25-30% of people with ZES.<br />\r\n<br />\r\nPeople who have a single MEN1-related tumor (such as one gastrinoma) and no family history of multiple endocrine neoplasia type 1 are rarely born with <em>MEN1</em> gene mutations. Generally, the chance of detecting a <em>MEN1</em> gene mutation increases in people with more main tumors (parathyroid, pancreatic, and pituitary).[7103]<br />\r\n<br />\r\nGenetic testing is most informative for asymptomatic family members when the affected family member has genetic testing first. The person with symptoms of MEN1 typically first has sequencing analysis of the gene to look for changes; if no mutation is found, they may have duplication/deletion analysis (a test that detects extra or missing parts of the gene).[7103]<br />\r\n<br />\r\nPredictive testing for at-risk, asymptomatic, adult family members requires first finding the disease-causing mutation in the affected family member. It is important to note that in people with a <em>MEN1</em> gene mutation, the chance to develop symptoms by age 20 is over 50%. The chance to develop symptoms by age 40 is 95%.[7103] Therefore, as a person ages and does not have signs or symptoms, the chance to have a <em>MEN1</em> gene mutation decreases significantly.<br />\r\n<br />\r\nThe <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0025267/\" target=\"_blank\">Genetic Testing Registry (GTR)</a> provides information about the genetic tests for multiple endocrine neoplasia type 1. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.","dateModified":"2014-01-14T15:35:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":7103,"authors":"Francesca Giusti, Francesca Marini, and Maria Luisa Brandi","articleTitle":"Multiple Endocrine Neoplasia Type 1","bookWebsiteJournalTitle":"GeneReviews","date":"February 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1538/","dateAccessed":"2014-04-05T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7197,"questionText":"What should I think about when considering predictive genetic testing?","answerText":"<a href=\"http://ghr.nlm.nih.gov/glossary=predictivetesting\" target=\"_blank\">Predictive genetic testing</a> may be available to people with a family history of a genetic condition who have a potential risk of eventually developing the condition. Depending on the condition, a predictive test may show whether a person will definitely develop the condition (<a href=\"http://ghr.nlm.nih.gov/glossary=presymptomatictesting\" target=\"_blank\">pre-symptomatic testing</a>) or has an increased chance to develop the condition (susceptibility testing).[7104] Predictive testing may be considered if:[7104][7106]\r\n<br />\r\n<br />\r\n<ul>\r\n    <li>the condition can be prevented or its symptoms can be treated</li>\r\n    <li>the condition cannot be prevented or treated, but knowing the chance of getting the condition may help with important life decisions (such as decisions about health care, employment, or having children)</li>\r\n    <li>a person can lower the risk to develop the condition by making lifestyle changes, having regular screening, taking preventative drugs, or having preventative surgery (e.g., for some hereditary cancer syndromes)</li>\r\n    <li>a person prefers to live with certainty rather than uncertainty regarding knowing whether they will develop the condition</li>\r\n</ul>\r\n<p>Even when a predictive test result is positive, it is usually not possible to predict the exact age that symptoms will develop, how fast symptoms will progress, or how a person will  be affected. Because there is no going back after a person gets results, it is important to think through some of the main issues before deciding whether to have testing.[7104] Each person may have specific concerns relevant to their own situation.</p>\r\n<p>\r\nSome questions to think about before making a decision may include:[7104]</p>\r\n<ul>\r\n    <li>How might the test results affect me emotionally?</li>\r\n    <li>How might I react if the result reveals that I carry the changed gene? For some people, even a result which shows that they have the changed gene is preferable to the stress and anxiety caused by not knowing.</li>\r\n    <li>How might I react if the result reveals that I do not carry the changed gene?</li>\r\n    <li>What might the test results mean for my children (or future children)? The results of a genetic test will not only tell you about your risk of developing the condition, it will also tell you more about your children's risk.</li>\r\n    <li>What are the implications for other family members? Many family members share the same genes, so testing for one family member may have implications for others.</li>\r\n</ul>\r\n<p>People who are considering having a predictive genetic test should speak with a genetics professional. Genetics professionals can provide the information needed in order for each person to make the decision that is right for them. They can explain the advantages and disadvantages of having the test; help to discuss any emotions that may arise; and address questions or concerns, including those about reproductive decision-making, privacy, and insurance.</p>","dateModified":"2014-10-01T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":7104,"authors":"","articleTitle":"Predictive Testing","bookWebsiteJournalTitle":"Genetic Interest Group","date":"March, 2009","volume":"","pages":"","url":"http://www.geneticalliance.org.uk/docs/PredictiveTesting.pdf","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7106,"authors":"","articleTitle":"Predictive genetic tests for cancer risk genes","bookWebsiteJournalTitle":"NHS","date":"June 26, 2013","volume":"","pages":"","url":"http://www.nhs.uk/Conditions/predictive-genetic-tests-cancer/Pages/Introduction.aspx","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2567,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by  the <a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>&nbsp;and the&nbsp;<a href=\"https://www.findageneticcounselor.com/\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also <a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a> from Genetics Home Reference.","dateModified":"2017-12-06T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13433,"phenoTypeName":"Zollinger-Ellison syndrome","frequencyText":"Obligate","percentRanges":"100%"},{"phenoTypeId":13766,"phenoTypeName":"Duodenal ulcer","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14338,"phenoTypeName":"Episodic abdominal pain","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":124,"phenoTypeName":"Esophagitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13408,"phenoTypeName":"Nausea","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10363,"phenoTypeName":"Peptic ulcer","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5059,"phenoTypeName":"Weight loss","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15585,"phenoTypeName":"Adrenocortical adenoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14476,"phenoTypeName":"Elevated circulating parathyroid hormone level","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11167,"phenoTypeName":"Erythema","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5967,"phenoTypeName":"Extrahepatic cholestasis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2306,"phenoTypeName":"Glucagonoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6046,"phenoTypeName":"Growth hormone excess","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14337,"phenoTypeName":"Hematochezia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14530,"phenoTypeName":"Hypercalcemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6045,"phenoTypeName":"Hyperparathyroidism","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14565,"phenoTypeName":"Increased circulating cortisol level","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14752,"phenoTypeName":"Increased glucagon level","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1660,"phenoTypeName":"Increased urinary cortisol level","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13532,"phenoTypeName":"Intestinal obstruction","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10276,"phenoTypeName":"Jaundice","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1662,"phenoTypeName":"Lipoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8292,"phenoTypeName":"Multiple lipomas","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1382,"phenoTypeName":"Parathyroid hyperplasia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15603,"phenoTypeName":"Pituitary corticotropic cell adenoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12233,"phenoTypeName":"Pituitary growth hormone cell adenoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12234,"phenoTypeName":"Pituitary null cell adenoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12113,"phenoTypeName":"Pituitary prolactin cell adenoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6023,"phenoTypeName":"Thyroid adenoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":103,"phenoTypeName":"Adrenocortical carcinoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":14183,"phenoTypeName":"Abnormality of the thyroid gland","percentRanges":"-"},{"phenoTypeId":15147,"phenoTypeName":"Adenoma sebaceum","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":10286,"phenoTypeName":"Cafe-au-lait spot","percentRanges":"-"},{"phenoTypeId":1906,"phenoTypeName":"Carcinoid tumor","percentRanges":"-"},{"phenoTypeId":58,"phenoTypeName":"Confetti-like hypopigmented macules","percentRanges":"-"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","percentRanges":"-"},{"phenoTypeId":13041,"phenoTypeName":"Hypoglycemia","percentRanges":"-"},{"phenoTypeId":6061,"phenoTypeName":"Increased circulating prolactin concentration","percentRanges":"-"},{"phenoTypeId":4899,"phenoTypeName":"Insulinoma","percentRanges":"-"},{"phenoTypeId":15588,"phenoTypeName":"Pancreatic islet cell adenoma","percentRanges":"-"},{"phenoTypeId":4306,"phenoTypeName":"Parathyroid adenoma","percentRanges":"-"},{"phenoTypeId":4302,"phenoTypeName":"Pituitary adenoma","percentRanges":"-"},{"phenoTypeId":13932,"phenoTypeName":"Prolactinoma","percentRanges":"-"},{"phenoTypeId":8310,"phenoTypeName":"Subcutaneous lipoma","percentRanges":"-"}],"medicalProducts":[{"productId":97,"genericName":"Synthetic human secretin","tradeName":"ChiRhoStim","tradeLink":"http://www.chirhostim.com/","manufacturer":"","sponsor":"ChiRhoClin, Inc.","indication":"For use in the diagnosis of gastrinoma associated with Zollinger-Ellison syndrome.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/rn/914454-02-7","medlinePlusLink":""},{"productId":98,"genericName":"Synthetic porcine secretin","tradeName":"Synthetic porcine secretin","tradeLink":"http://www.chirhoclin.com/Products.htm","manufacturer":"","sponsor":"ChiRhoClin, Inc.","indication":"For use in secretin stimulation testing for: Stimulation of pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangio-pancreatography (ERCP)","drugInformationLink":"","medlinePlusLink":""}],"EncodedName":"Zollinger-Ellison_syndrome"}